Peer Review History
| Original SubmissionMay 28, 2025 |
|---|
|
Dear Dr. Breton, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The reviewers were positive about the manuscript but described some areas that would benefit from improvements. In particular, providing contextual information on the setting and the measurement tools used. Please see the detail of the comments below. Please submit your revised manuscript by Oct 26 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Aliah Faisal Shaheen Academic Editor PLOS ONE Journal Requirements: Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information. 3. Thank you for stating the following in the Competing Interests section: “I have read the journal's policy and the authors of this manuscript have the following competing interests: AT mentioned that a family member is working for a pharmaceutical company. She also received an honorarium as consultant to evaluate the GAP implementation in Quebec from MSSS.” Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf. 4. We note that you have indicated that there are restrictions to data sharing for this study. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Before we proceed with your manuscript, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible. We will update your Data Availability statement on your behalf to reflect the information you provide. 5.If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: Strengths of the Study - Use of a very large, multi-site patient sample enhances generalizability of findings. - Patient-centered outcomes are measured using validated PREM tools, directly reflecting patient experiences. - Application of the Andersen behavioral model allows nuanced analysis of predisposing, enabling, and need factors. - Stratified regression models by GAP orientation provide granular insights into modality-specific issues. - The authors contextualize findings within ongoing healthcare reforms and recent changes to physician incentive structures, revealing important external influences. Areas for Improvement and Additional Considerations - Response Rate and Representativeness The response rate in this study warrants critical attention in evaluating the generalizability of its findings. As recruitment relied on email invitations, there is a risk of underrepresenting vulnerable groups (elderly, low-income, or digital literacy-limited populations). Please provide further discussion of this limitation, and—if feasible—consider applying or discussing sample weighting strategies to address non-response and improve credibility. According to the manuscript: A total of 212,546 patients with valid email addresses were invited to participate in the survey from a pool of approximately 279,000 unattached patients registered across three local health territories (LHTs) in Quebec. Of these, 41,384 individuals responded, yielding an overall response rate of approximately 19% among those invited. Among respondents, 20,282 individuals both responded on their own behalf and had used the GAP service—forming the analytic sample. This implies that the analyzed data represents only about 9.5% of invited individuals, and approximately 7.3% of the total unattached patient population in the target regions. - Limitations of the GAP Model for Core Primary Care Functions The current GAP model is optimized for prompt, acute care. I recommend a more explicit discussion of the structural gaps in preventive, chronic, and continuous care for unattached patients, and—if possible—suggest strategies or policy directions to address these limitations. - Definition of Unmet Need As the measurement of unmet need was specifically focused on the GAP encounter for the main reported reason, emphasize this scope in both Results and Discussion. Also, mention as a limitation that multiple, concurrent unmet needs may exist, particularly among complex patients. - Patient–Provider Education in Team-Based Care Since unmet need was substantially higher for non-physician provider orientations, the discussion should address not only patient expectations but also opportunities for better communication, patient education, and acceptance of diverse provider roles within interprofessional primary care. - Conclusion and Recommendation - While the study offers valuable insights into the characteristics and experiences of GAP users who responded to the survey, its findings should not be generalized to all unattached patients in Quebec without caution. Future studies would benefit from: Comparative analyses of respondent vs. nonrespondent characteristics, application of population weights or statistical correction methods, and use of alternative survey modalities (e.g., phone, mail) to reach digitally underserved populations. Overall, this is an important study that substantially contributes to our understanding of access models for unattached patients and the design of team-based primary care systems. The large-scale, real-world data, careful methodology, and clear policy relevance are strengths. Provided that the authors address the above points—particularly around issues of representativeness, the definition of unmet need, and strategies to build acceptance and effectiveness of team-based care—I find this manuscript suitable for publication in PLOS ONE. Reviewer #2: Dear Authors, It is very interesting and valuable topic of research as the objectives of this study are to" 1) document the factors associated with unmet healthcare needs after receiving a GAP service and 2) assess if these factors vary according to GAP service received" So goals of research confirm the importance of the research as well as they are clearly specified. Introduction contains not only the description of purposes of the research but also the importance of primary health and unmet needs are well explained. Also factors, which are responsible for unmet needs are mentioned and they apply to Canada. So, it would be worth to make also some literature research of healthcare system, which are similar type of Canada in purpose to see also what are the factors of unmet needs and then to consider them also if they are different. So, readers should be aware if they are the same etc.. Methodology is well explained and especially the questionnaire. Results and discussion are well presented. However the practical and theoretical implications should be expended. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 1 |
|
Dear Dr. Breton,
plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Aliah Faisal Shaheen Academic Editor PLOS ONE Journal Requirements: 1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Reviewer #1: Thank you for your detailed response addressing the concerns raised regarding the response rate and representativeness. I appreciate the authors’ clear acknowledgment of the limitations inherent in using an email-based recruitment strategy, as well as the expanded discussion provided in the revised manuscript. Your explanation regarding the lack of available population characteristics for unattached patients across the three LHTs—and the high turnover within the CWL—offers a reasonable justification for why weighting strategies were not feasible. That said, I encourage the authors to further strengthen the manuscript in two areas: 1. Interpretation of the potential impact on study findings. While the limitations are acknowledged, the revised version does not sufficiently discuss how low representativeness may affect the direction or magnitude of key results. Because the analytic sample represents only about 7% of the unattached population, it would be helpful to explicitly address how overrepresentation of individuals with higher digital access might influence estimates of unmet healthcare needs or the distribution of GAP orientations. 2. Consideration of alternative post-hoc adjustment approaches. Even if full weighting was not possible, it may still be beneficial to briefly note whether any partial adjustment strategies were considered—such as LHT-level calibration, or comparisons with publicly available demographic data. Stating that such options were evaluated but deemed infeasible would improve transparency in methodological decision-making. Your revisions are appreciated and address the core of the concern; however, a modest additional elaboration on these points would better contextualize the implications of non-response and representativeness limitations for readers and policymakers who may rely on these findings. Minor Comments 1. Figures and Tables Please improve the readability of Figure 2 by using clearer labels or considering an alternative graphical format. Ensure consistent formatting of statistically significant results across tables (e.g., bolding, decimal places). Add the following footnote to Table 1 to define all abbreviations: LHT: Local Health Territory CWL: Centralized Waiting List for Unattached Patients GAP: Primary Care Access Point for Unattached Patients 2. Clarity and Grammar Minor edits are needed to improve clarity: “an in-depth exploration the reasons” → “an in-depth exploration of the reasons” Thank you again for your careful revisions. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 2 |
|
Dear Dr. Breton,
plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Aliah Faisal Shaheen Academic Editor PLOS One Journal Requirements: 1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Reviewer #1: The revised manuscript has improved substantially since the previous submission and now presents a clear and well-structured analysis of unmet healthcare needs among unattached patients using Primary Care Access Points (GAP). The study addresses a relevant primary care issue, and the analytical approach is generally appropriate. Most of the major concerns raised in the previous review have been adequately addressed. However, a few minor issues related to reporting clarity remain and should be corrected before final acceptance. First, in Table 3, adjusted odds ratios (AORs) are presented, but the table footnote does not specify which covariates were included in the adjusted model. For transparency and ease of interpretation, the authors should clearly state in the footnote the variables adjusted for in the multivariable analysis. Second, Table 4 raises the same issue as Table 3. Adjusted estimates are shown, yet the corresponding footnote does not describe the adjustment variables. Consistent reporting across tables is important, and Table 4 should include a footnote specifying the covariates used in the adjusted analysis, in parallel with Table 3. Third, all tables should be self-explanatory, with clear definitions of abbreviations used. In particular, the abbreviation “GAP” should be defined in the footnote of each table where it appears, even if it has been defined elsewhere in the text. Overall, the authors have responded appropriately to the previous reviewer comments, and the remaining issues are minor and editorial in nature. These can be addressed easily without additional analysis. I recommend acceptance after minor revision, and further external peer review does not appear necessary. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 3 |
|
Factors associated with unmet healthcare needs in patients using Primary Care Access Points for unattached patients in Quebec (Canada) PONE-D-25-23656R3 Dear Dr. Breton, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Aliah Faisal Shaheen Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-23656R3 PLOS One Dear Dr. Breton, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Aliah Faisal Shaheen Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .